Moderna, Inc. MRNA announced the dosing of the first participant in the phase III Nova 301 study, which is evaluating its ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

GSK’s ex-head of vaccines says its blockbuster jab for a flu-like virus that spreads in the autumn and winter is too ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

With respiratory viruses ramping up as we look to cooler days, vaccination season has arrived again. The newest vaccine to protect against Covid-19 has hit pharmacies, and Allegheny County residents ...

Moderna 's ( MRNA -2.63%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

“Right now is the best time” to get all the recommended fall vaccinations, said Dr. Mandy Cohen, director of the Centers for ...

Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.

The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA ) between January 18, 2023 and June 25, 2024, both dates inclusive (the "Class ...

Two Montgomery County commissioners rolled up their sleeves and got vaccinated, receiving their flu and COVID-19 shots during ...